RENEURON (RENE)

 

RENEURON (RENE.L, LSE, LSE:RENE)

RENE Share PerformanceMore

52 week high6.500 15/07/15
52 week low2.800 22/01/15
52 week change 1.850 (52.48%)
4 week volume32,146,463 04/08/15

Media for (RENE)

Presenter: Michael Hunt, CEO
04/02/2015

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Notification of Major Interest in Shares

RNS Number: 4971X ReNeuron Group plc 28 August 2015 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ReNeuron Group plc 2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of voting rights An acquisit...

Notification of Major Interest in Shares

RNS Number: 3695X ReNeuron Group plc 28 August 2015 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: Reneuron Group 2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of voting rights No An acquisiti...

Notification of Major Interest in Shares

RNS Number: 2273X ReNeuron Group plc 27 August 2015 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ReNeuron Group plc 2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of voting rights An acquisi...

ReNeuron schedules AGM

ReNeuron will hold its annual general meeting at the offices of Covington & Burling LLP, 265 Strand, London, WC2R 1BH...

Notification of Major Interest in Shares

RNS Number: 1091X ReNeuron Group plc 26 August 2015 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ReNeuron Group plc 2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of voting rights X An acqui...

Posting of Annual Report and Notice of AGM

RNS Number: 0765X ReNeuron Group plc 26 August 2015 26 August 2015 AIM: RENE ReNeuron Group plc ("ReNeuron" or the "Company") Posting of Annual Report and Accounts and Notice of AGM Guildford, UK, 26 August 2015: ReNeuron Group plc, a leading UK-based stem cell therapy company, announces that its Annual Report and Accounts for the year...

ReNeuron confirms share placing

ReNeuron Group announced on 21 August 2015 that shareholders had approved all the resolutions in connection with the P...

Completion of Placing and TVR

RNS Number: 9911W ReNeuron Group plc 25 August 2015 25 August 2015 AIM: RENE ReNeuron Group plc ("ReNeuron" or the "Company") Completion of Placing and Total Voting Rights Guildford, UK, 25 August 2015: ReNeuron Group plc, a leading UK-based stem cell therapy company, announced on 21 August 2015 that shareholders had approved all the resolu...

Fundamental DataMore

EPS-0.5
Dividend yield0 %

Equity Research (RENE)

edison investment research
ReNeuron Group plc
23/04/2015
ReNeuron presented two-year follow-up data from the PISCES study in disabled stroke patients, which confirm the potential for long-term benefits from treatment with its CTX neural stem cells....
edison investment research
ReNeuron Group plc
28/11/2014
ReNeuron is facing a potentially transformational year in 2015, with key clinical data and relocation to a new cell manufacturing/research facility. Its allogeneic, CTX neural stem cell product is...
edison investment research
ReNeuron Group plc
29/09/2014
ReNeuron operates off solid fundamentals as it seeks to advance its novel stem cell technology. Last year’s £25.3m fundraise coupled with a £7.8m grant from the Welsh government to build a new...

Users' HoldingsMore

Users who hold RENEURON also hold..
LLOYDS GRP.13%
BP12%
GLAXOSMITHKLINE12%
BARCLAYS12%
ROYAL BANK SCOT10%

Codes & Symbols

ISINGB00B0DZML60
SymbolsRENE, LSE:RENE, RENE.L, RENE:LN, LON:RENE, XLON:RENE